Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2025-12-26 @ 4:04 PM
NCT ID: NCT03590106
Eligibility Criteria: Inclusion Criteria: All patients considered for this program must meet the following criteria: 1. Must be at least 18 years of age and able to provide consent 2. Must speak/read/understand English 3. Currently hospitalized and physically located on 7-3600 unit 4. Followed by or on the Cardiac Surgery service 5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug use (IVDU) 6. Alert and oriented to person, place, time, and events leading up to hospitalization 7. Able to carry on a coherent conversation 8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no adjunctive (opioids) medication use within past 24 hours a. If COW score is greater than five or adjunctive medications have been used within the previous 24 hours, the patient will be re-evaluate every 24 hours until score is less than or equal to five and no adjunctive medications used within the previous 24 hours Exclusion Criteria: 1. Under the age of 18 years old 2. Unable to speak/read/understand English 3. Hospitalized but not on 7-3600 4. Does not have a diagnosis of endocarditis associated with IVDU 5. Not followed by or on the Cardiac Surgery service 6. Not Alert or oriented or unable to carry on a coherent conversation 7. COW score that is greater than five or adjunctive medications have been used within the previous 24 hours (see inclusion criteria)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03590106
Study Brief:
Protocol Section: NCT03590106